ACN vs ALB Stock Comparison
Scores Breakdown
| Metric | ACN | ALB |
|---|---|---|
| 📈 Growth | 28/30 | 27/30 |
| 💰 Profitability | 16/20 | 15/20 |
| 🏦 Financial Health | 18/20 | 18/20 |
| 💵 Valuation | 15/20 | 14/20 |
| ⚠️ Risk (lower is better) | 5/10 | 7/10 |
| Overall Score | 82/100 | 77/100 |
Side-by-Side Summaries
| ACN Analysis | ALB Analysis |
|---|---|
📈 Growth & Financial TrajectoryOver the eight quarters, Revenues rose from $17.69B to $18.72B, while Net Income increased from $1.79B to $2.34B, signaling a positive trajectory with modest top-line growth and stronger bottom-line advancement. The trend shows resilience amid quarterly fluctuations, with mid-single-digit revenue growth and improving profitability. 💰 Margins & Cash FlowGross Margin sits in the low 30s (about 32%–33%), and Operating Margin runs in the mid-teens, supporting the Net Income growth. Cash flow is robust: Net Cash Flow From Operating Activities around $3.0–3.8B per quarter; Net Cash Flow overall was positive in several periods, while Net Cash Flow From Investing Activities and Net Cash Flow From Financing Activities show volatility. 🛡️ Balance Sheet & LiquidityLiquidity remains solid with Current Assets around $25–29B versus Current Liabilities around $18–22B (current ratio near 1.3x). Equity sits near $31–33B, and overall liabilities are manageable relative to assets. ⚠️ Key Drivers & Risks
|
📈 Growth & Financial TrajectoryAcross eight quarters, ALBEMARLE shows modest revenue growth from about $1.43B in 2024-Q2 to $1.74B in 2026-Q2, a gain of ~22%. Net income evolved from a loss of about -$176.6M to a positive $499.2M in 2026-Q2, with a mid-2025 dip, then a clear recovery into 2026. 💰 Margins & Cash FlowGross margin expanded from a negative figure in 2024-Q2 to roughly 35% in 2025-Q1 and remained around the high 30% into 2026. Operating leverage benefited from higher margin production in later quarters. Net cash flow from operating activities, continuing, stayed strong, with $709.997M in 2026-Q2 and positive quarterly cash generation overall. Free cash flow was primarily consumed by investing activities, which were negative but the company still reported a positive overall cash flow in 2026-Q2. 🛡️ Balance Sheet & LiquidityTotal assets of about $15.9B and equity of ~$10.5B support a solid balance sheet. Current assets of roughly $3.9B and current liabilities of $1.89B yield a healthy current ratio around 2.1x. Long-term debt remains moderate at about $1.88B, keeping balance-sheet risk contained. ⚠️ Key Drivers & Risks
|